| 000 | 01739 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516161640.0 | ||
| 264 | 0 | _c20131231 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1479-5876 | ||
| 024 | 7 |
_a10.1186/1479-5876-11-173 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPan, Yuanming | |
| 245 | 0 | 0 |
_aMetallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection. _h[electronic resource] |
| 260 |
_bJournal of translational medicine _cJul 2013 |
||
| 300 |
_a173 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin D1 _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aI-kappa B Proteins _xmetabolism |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetallothionein _xmetabolism |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aStomach Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHuang, Jiaqiang | |
| 700 | 1 | _aXing, Rui | |
| 700 | 1 | _aYin, Xin | |
| 700 | 1 | _aCui, Jiantao | |
| 700 | 1 | _aLi, Wenmei | |
| 700 | 1 | _aYu, Jun | |
| 700 | 1 | _aLu, Youyong | |
| 773 | 0 |
_tJournal of translational medicine _gvol. 11 _gp. 173 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1479-5876-11-173 _zAvailable from publisher's website |
| 999 |
_c22932644 _d22932644 |
||